Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodents

Bone

Volumn 36, Issue 2, 2005, Pages 202-214

  Kneissel, Michaela ^a   Studer, Anne ^a   Cortesi, Reto ^a   Šuša, Mira ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Bone turnover; Computed tomography; Cortical bone; Histomorphometry animal; Osteoclasts

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID ETHYL ESTER; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; RETINOIC ACID DERIVATIVE; RETINOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; BONE FRAGILITY; BONE MARROW CELL; BONE MASS; BONE TURNOVER; CANCELLOUS BONE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DRUG POTENCY; FEMALE; GEOMETRY; HINDLIMB; IN VIVO STUDY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; PERIOSTEUM; PHARMACOLOGICAL BLOCKING; QUANTITATIVE ANALYSIS; RAT;

EID: 14144249360     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.11.006     Document Type: Article

References (43)

1. R. Armstrong, K. Ashenfelter, C. Eckoff, A. Levin, and S. Shapiro General and reproductive toxicology of retinoids M. Sporn A. Roberts D. Goodman The Retinoids vol. 1 1994 Raven New York 545 572
2. W.G. Beamer, L.R. Donahue, C.J. Rosen, and D.J. Baylink Genetic variability in adult bone density among inbred strains of mice Bone 18 1996 397 403
3. N. Binkley, and D. Krueger Hypervitaminosis A and bone Nutr. Rev. 58 2000 138 144
4. H.U. Bryant, A.L. Glasebrook, N.N. Yang, and M. Sato An estrogen receptor basis for raloxifene action in bone J. Steroid Biochem. Mol. Biol. 69 1999 37 44
5. D. Cappellen, N.H. Luong-Nguyen, S. Bongiovanni, O. Grenet, C. Wanke, and M. Susa Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B J. Biol. Chem. 277 2002 21971 21982
6. S. Colucci, M. Grano, G. Mori, K. Scotlandi, M. Mastrogiacomo, and C. Mori Retinoic acid induces cell proliferation and modulates gelatinases activity in human osteoclast-like cell lines Biochem. Biophys. Res. Commun. 227 1996 47 52
7. J.P. David, L. Neff, Y. Chen, M. Rincon, W.C. Horne, and R. Baron A new method to isolate large numbers of rabbit osteoclasts and osteoclast-like cells: application to the characterization of serum response element binding proteins during osteoclast differentiation J. Bone Miner. Res. 13 1998 1730 1738
8. A. Dhem, and M. Goret-Nicaise Effects of retinoic acid on rat bone Food Chem. Toxicol. 22 1984 199 206
9. D. Feskanich, V. Singh, W.C. Willett, and G.A. Colditz Vitamin A intake and hip fractures among postmenopausal women JAMA 287 2002 47 54
10. T.L. Frankel, M.S. Seshadri, D.B. McDowall, and C.J. Cornish Hypervitaminosis A and calcium-regulated hormones in the rat J. Nutr. 116 1986 578 587
11. J.A. Gasser Bone measurements by peripheral quantitative computed tomography in rodents Methods Mol. Med. 80 2003 323 341
12. S. Hough, L.V. Avioli, H. Muir, D. Gelderblom, G. Jenkins, and H. Kurasi Effects of hypervitaminosis A on the bone and mineral metabolism of the rat Endocrinology 122 1988 2933 2939
13. Y. Ishimi, M. Ohmura, X. Wand, M. Yamaguchi, and S. Ikegami Inhibition by caretenoids and retinoic acid of osteoclast-like cell formation induced by bone-resorbing agents in vitro J. Clin. Biochem. Nutr. 27 1999 113 122
14. M.J. Jimenez, M. Balbin, J. Alvarez, T. Komori, P. Bianco, and K. Holmbeck A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation J. Cell Biol. 155 2001 1333 1344
15. S. Johansson, P. Lind, H. Hakansson, J. Oxlund Hoeberg, and H. Melhus Subclinical hypervitaminosis A causes fragile bones in rats Bone 31 2002 685 689
16. H. Kaji, T. Sugimoto, M. Kanatani, M. Fukase, M. Kumegawa, and K. Chihara Retinoic acid induces osteoclast-like cell formation by directly acting on hemopoietic blast cells and stimulates osteopontin mRNA expression in isolated osteoclasts Life Sci. 56 1995 1903 1913
17. M. Kneissel, A. Boyde, and J.A. Gasser Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34) Bone 28 2001 237 250
18. P. Loeliger, W. Bollag, and H. Mayer Arotinoids, a new class of highly active retinoids Eur. J. Med. Chem. 15 1980 9 10
19. H. Melhus, K. Michaelsson, A. Kindmark, R. Bergstrom, L. Holmberg, and H. Mallmin Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture Ann. Intern. Med. 129 1998 770 778
20. K. Michaelsson, H. Lithell, B. Vessby, and H. Melhus Serum retinol levels and the risk of fracture N. Engl. J. Med. 23 348 2003 287 294
21. T. Moore, Y. Wang, and A. Hypervitaminosis Biochem. J. 39 1945 222 228
22. Y. Nakayama, K. Takahashi, S. Noji, K. Muto, K. Nishijima, and S. Taniguchi Functional modes of retinoic acid in mouse osteoblastic clone MC3T3-E1, proved as a target cell for retinoic acid FEBS Lett. 261 1990 93 96
23. K. Ohishi, S. Nishikawa, T. Nagata, N. Yamauchi, H. Shinohara, and J.-I. Kido Physiological concentrations of retinoic acid suppress the osteoblastic differentiation of fetal rat calvaria cells in vitro Eur. J. Endocrinol. 133 1995 335 341
24. R.P. O'Neill, S.J. Jones, A. Boyde, M.L. Taylor, and T.R. Arnett Effect of retinoic acid on the resorptive activity of chick osteoclasts in vitro Bone 13 1992 23 27
25. A.M. Parfitt, M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, and P.J. Meunier Bone histomorphometry: standardization of nomenclature, symbols, and units J. Bone Miner. Res. 2 1987 595 608
26. C.K. Park, Y. Ishimi, M. Ohmura, M. Yamaguchi, and S. Ikegami Vitamin A and carotenoids stimulate differentiation of mouse osteoblastic cells J. Nutr. Sci. Vitaminol. 43 1997 281 296
27. J.H. Promislow, D. Goodman-Gruen, D.J. Slymen, and E. Barrett-Connor Retinol intake and bone mineral density in the elderly: the Rancho Bernardo Study J. Bone Miner. Res. 17 2002 1349 1358
28. I. Recchia, N. Rucci, A. Funari, S. Migliaccio, A. Taranta, and M. Longo Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]- pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway Bone 34 2004 65 79
29. M.J. Rogers New insights into the molecular mechanisms of action of bisphosphonates Curr. Pharm. Des. 9 2003 2643 2658
30. S. Saneshige, H. Mano, K. Tezuka, S. Kakudo, Y. Mori, and Y. Honda Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K/OC-2 Biochem. J. 309 1995 721 724
31. E. Seeman Periosteal bone formation-A neglected determinant of bone strength N. Engl. J. Med. 349 2003 320 323
32. E. Seeman The structural and biomechanical basis of the gain and loss of bone strength in women and men Endocrinol. Metab. Clin. North Am. 32 2003 25 38
33. N.K. Shevde, A.C. Bendixen, K.M. Dienger, and J.W. Pike Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression Proc. Natl. Acad. Sci. U. S. A. 97 2000 7829 7834
34. H. Sudo, H.A. Kodama, Y. Amagai, S. Yamamoto, and S. Kasai In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria J. Cell Biol. 96 1983 191 198
35. M. Susa, and A. Teti Tyrosine kinase src inhibitors: potential therapeutic applications Drug News Perspect. 13 2000 169 175
36. M. Susa, N.H. Luong-Nguyen, D. Cappellen, N. Zamurovic, and R. Gamse Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay J. Transl. Med. 2 2004 6
37. L. Takahashi, Z. Nakamiya, K. Kawakimi, and T. Kitasato Sci. Pap. Inst. Phys. Chem. Res. 3 1925 81 148
38. K. Teelmann Retinoids: toxicology and teratogenicity to date Pharmacol. Ther. 40 1989 29 43
39. X. Wang, J. Wu, Y. Shidoji, Y. Muto, N. Ohishi, and K. Yagi Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation J. Bone Miner. Res. 17 2002 91 100
40. F.H. Wezeman, J. Corey, and B. Waxler Osteoblast low-molecular-weight proteinase inhibitor: I. Isolation and characterization of activity from osteoblastic cells and bone Calfic. Tissue Int. 46 1990 263 269
41. B. Wu, B. Xu, T.Y. Huang, and J.R. Wang A model of osteoporosis induced by retinoic acid in male Wistar rats Yao Xue Xue Bao 31 1996 241 245
42. T. Yan, J. Wergedal, Y. Zhou, S. Mohan, D.J. Baylink, and D.D. Strong Inhibition of human osteoblast marker gene expression by retinoids is mediated in part by insulin-like growth factor binding protein-6 Growth Horm. IGF Res. 11 2001 368 377
43. N. Zamurovic, D. Cappellen, D. Rohner, and M. Susa Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogeneticic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity J. Biol. Chem. 279 2004 37704 37714